carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - кармустином - hodgkin disease; lymphoma, non-hodgkin - Антинеопластични средства - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
ranitidine sopharma 150 mg film - coated tablets
СОФАРМА АД - Ранитидин - 150 mg film - coated tablets
ranitidine sopharma 25 mg/ml solution for injection
СОФАРМА АД - Ранитидин - 25 mg/ml solution for injection
ranitidine accord 300 mg film - coated tablets
accord healtcare ltd. - Ранитидин - 300 mg film - coated tablets
rohomustin 2,5 mg/ml powder for concentrate for solution for infusion
sandoz d.d. - bendamustin - 2,5 mg/ml powder for concentrate for solution for infusion
bendamustine actavis 2,5 mg/ml powder for concetrate for solution fo infusion
actavis group ptc ehf - bendamustin - 2,5 mg/ml powder for concetrate for solution fo infusion
mustophoran 208 mg powder and solvent for solution for infusion
les laboratoires servier - fotemustine - 208 mg powder and solvent for solution for infusion
carmustine teva 100 mg powder and solvent for solution for infusion
100 mg powder and solvent for solution for infusion
bendamustine accord 2,5 mg/ml powder for concetrate for solution for infusion
2,5 mg/ml powder for concetrate for solution for infusion
bendamustine helm 2,5 mg/ml powder powder for concetrate for solution for infusion
2,5 mg/ml powder powder for concetrate for solution for infusion